Interferon alfa, peginterferon alfa and retinopathy.
(1) Retinal damage is a known adverse effect of interferon alfa. (2) Similar adverse effects have been reported with pegylated interferon alfa. The disorders generally regress within a few months, despite continued treatment.
D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006526:Hepatitis C / Q000188:drug therapy; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012164:Retinal Diseases / Q000139:chemically induced*
D000998:Antiviral Agents; D016898:Interferon-alpha; D011092:Polyethylene Glycols